Skip to main content

Table 1 Demographic and clinical characteristics of study women at the time of enrollment (n = 994)

From: Medication exposure during pregnancy: a pilot pharmacovigilance system using health and demographic surveillance platform

Characteristics

First trimester

Second trimester

Total

 

n = 323

n = 671

n = 994

Mean age, (years)*

26.4 (7.3; 14–49)

26.8 (7.0; 14–46)

26.6 (7.0; 14–49)

Mean BMI*

23.1 (3.8; 14.2-39.6)

23.4 (3.4; 14.0-42.5)

23.3 (3.6; 14.0-42.5)

Mean gestational age, (weeks)*

10.0 (2.2; 3–12)

16.6 (1.9; 13–20)

14.8 (3.6; 3–20)

Gravidity#

   

 Primigravidae

82 (25.4)

198 (29.5)

280 (28.2)

 Secundigravidae

62 (19.2)

113 (16.8)

175 (17.6)

 3 – 4 pregnancies

99 (30.7)

192 (28.6)

291 (29.3)

 ≥ 5 pregnancies

80 (24.8)

168 (25.1)

248 (24.9)

Recruited sites#

   

 Health facility

193 (59.8)

467 (69.6)

660 (66.4)

 Home

130 (40.2)

204 (30.4)

334 (33.6)

Drinking alcohol#

3 (0.9)

3 (0.4)

6 (0.6)

Smoking cigarette#

2 (0.6)

0 (0)

2 (0.2)

Mean haemoglobin level, (g/dl)*

7.8 (4.7; 6.0-12.7)

7.5 (4.6; 5.2-14.3)

7.7 (4.6; 5.2-14.3)

HIV status#

   

 Negative

284 (88.0)

603 (89.9)

887 (89.2)

 Positive

12 (3.7)

35 (5.2)

47 (4.7)

 No results

27 (8.3)

33 (4.9)

60 (6.0)

Syphilis test#

   

 Negative

288 (89.2)

628 (93.6)

916 (92.2)

 Positive

9 (2.8)

12 (1.8)

21 (2.1)

 No results

26 (8.0)

31 (4.6)

57 (5.7)

  1. *represents data presented in mean, (standard deviation [SD]; range).
  2. #represents data presented in number (%).
  3. Abbreviation: BMI Body Mass Index.